Here's why the BARD1 (ASX:BD1) share price is frozen today

All eyes are on BARD1 Life Sciences' halted shares.

| More on:
A dollar sign embedded in ice, indicating a share price freeze or trading halt

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The BARD1 Life Sciences Ltd (ASX: BD1) share price is frozen today as the company prepares to announce news of a capital raise.

Trading of its shares will be halted until it either releases an announcement or the ASX opens on Friday morning.

The BARD1 Life Science share price finished yesterday's session trading at $1.80.

The company is focused on creating non-invasive methods to detect early stage cancers.

Let's take a closer look at today's news of BARD1 Life Science.

Trading halt ahead of capital raise

The BARD1 Life Sciences share price is halted as it prepares to announce a $10 million placement and a $2 million share purchase plan. The share purchase plan is open to eligible retail investors.

The placement will see shares in BARD1 going for $1.55 apiece. That's a 13.88% discount on its previous closing price.

The company is currently working on autoantibody tests that have been proven to detect some early-stage cancers.

Its lead pipeline product is its ovarian cancer tests. It is also working to create tests for early stage breast cancer.

Also in BARD1's pipeline are tests for early stage lung cancer.

The BARD1 share price was temporarily boosted late last month by news its ovarian cancer detection technology had been published by international peer-reviewed journal Genes.

Today's news is the first time the market has heard of a capital raise by BARD1 since June 2019.

Back then, the company raised $7.5 million to put towards its growth strategy.

BARD1 Life Sciences share price snapshot

2021 has been a good year so far for the BARD1 Life Sciences share price.

Right now, it's 172% higher than it was at the start of the year. It has also gained 114% since this time last year.

The company has a market capitalisation of around $144 million, with approximately 80 million shares outstanding.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »

Father in the ocean with his daughters, symbolising passive income.
Dividend Investing

I'd spend $8k on these ASX 200 shares today to target a $6,102 annual passive income

I believe these ASX 200 shares will continue rewarding passive income investors for years to come.

Read more »

Three businesspeople leap high with the CBD in the background.
Share Market News

Boom! ASX 200 blasts to new record highs

ASX 200 investors just sent the benchmark index into uncharted territory.

Read more »